Samsung Biologics, a global contract development and manufacturing organization (CDMO), has extended its collaboration with ...

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its ...

Oxford, UK and San Jose, California, 9 January 2024 - (OBT), a clinical stage oncology company with a pipeline of ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, ...

After inking a series of partnerships late last year, Lonza’s antibody-drug conjugate (ADC) specialist Synaffix is kicking ...

Ingelheim, Germany Thursday, January 9, 2025, 15:00 Hrs [IST] ...

Apheresis Overview Apheresis is a medical technology used to separate various constituents of the blood, in which the remaining components of the blood are returned to the patient after extraction of ...

Key Takeaways from the Cardiac Arrhythmia Monitoring Devices Market Report .On November 13, 2024, SmartCardia received FDA clearance for its Mobile Outpatient Cardiac Telemetry (OCT/MCT) system, which ...

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...

Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.